- Investing Ideas
- Belgian Pharmaceuticals & Biotech Price disconnect
Belgian Pharmaceuticals & Biotech Price disconnect
Results
2
0 new
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
2 companies
UCB
Market Cap: €49.2b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€258.50
7D
3.5%
1Y
51.9%
argenx
Market Cap: €48.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€784.40
7D
1.4%
1Y
63.7%